ES2389775T3 - Producción y purificación de la proteína A sin emplear componentes de origen animal - Google Patents

Producción y purificación de la proteína A sin emplear componentes de origen animal Download PDF

Info

Publication number
ES2389775T3
ES2389775T3 ES06253985T ES06253985T ES2389775T3 ES 2389775 T3 ES2389775 T3 ES 2389775T3 ES 06253985 T ES06253985 T ES 06253985T ES 06253985 T ES06253985 T ES 06253985T ES 2389775 T3 ES2389775 T3 ES 2389775T3
Authority
ES
Spain
Prior art keywords
vegetable protein
protein
eluent
column
resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06253985T
Other languages
English (en)
Spanish (es)
Inventor
Thomas Richard Leary
Daniel Lafoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avantor Performance Materials LLC
Original Assignee
Avantor Performance Materials LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantor Performance Materials LLC filed Critical Avantor Performance Materials LLC
Application granted granted Critical
Publication of ES2389775T3 publication Critical patent/ES2389775T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES06253985T 2005-07-29 2006-07-31 Producción y purificación de la proteína A sin emplear componentes de origen animal Expired - Lifetime ES2389775T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US194093 2005-07-29
US11/194,093 US7375188B2 (en) 2005-07-29 2005-07-29 Vegetarian protein a preparation and methods thereof

Publications (1)

Publication Number Publication Date
ES2389775T3 true ES2389775T3 (es) 2012-10-31

Family

ID=36954658

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06253985T Expired - Lifetime ES2389775T3 (es) 2005-07-29 2006-07-31 Producción y purificación de la proteína A sin emplear componentes de origen animal

Country Status (5)

Country Link
US (2) US7375188B2 (cg-RX-API-DMAC7.html)
EP (1) EP1748063B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007039454A (cg-RX-API-DMAC7.html)
ES (1) ES2389775T3 (cg-RX-API-DMAC7.html)
PL (1) PL1748063T3 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY185597A (en) * 2005-09-20 2021-05-24 Avantor Performance Mat Inc Vegetarian protein a preparation and methods thereof
PL2117587T3 (pl) 2007-03-05 2018-07-31 Om Pharma Ekstrakt bakteryjny przeznaczony do stosowania względem zaburzeń układu pokarmowego lub moczowego i sposób jego wytwarzania
ES2761697T3 (es) * 2008-08-28 2020-05-20 Novartis Ag Proceso para preparar una emulsión de aceite en agua que contiene escualeno procedente de levaduras
EP2814514B1 (en) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
CN114717206A (zh) 2013-03-15 2022-07-08 Atyr 医药公司 组氨酰-trna合成酶-fc缀合物
JP6404821B2 (ja) * 2013-09-12 2018-10-17 国立大学法人 岡山大学 インターロイキン10産生促進剤
ES2994451T3 (en) 2017-04-20 2025-01-24 Atyr Pharma Inc Compositions for treating lung inflammation
CN106977591B (zh) * 2017-05-04 2020-05-05 广州康盛生物科技股份有限公司 一种分离纯化重组葡萄球菌蛋白a的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3625833A (en) * 1970-01-23 1971-12-07 James J Schaffer Process for producing antiviral substance from staphylococcus organisms
US4464165A (en) * 1980-11-24 1984-08-07 American Hoechst Corporation Material and method for removing immunoglobulins from whole blood
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4699783A (en) * 1983-03-11 1987-10-13 Terman David S Products and methods for treatment of cancer
US4617266A (en) 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
JPS61224997A (ja) 1985-03-29 1986-10-06 Chemo Sero Therapeut Res Inst プロテインaの精製方法
US4801687A (en) * 1986-10-27 1989-01-31 Bioprobe International, Inc. Monoclonal antibody purification process using protein A
EP0289129A3 (en) 1987-03-26 1990-10-10 Repligen Corporation High purity protein a preparation
ATE91152T1 (de) * 1988-07-22 1993-07-15 Imre Corp Gereinigte protein a-zusammensetzungen und verfahren zu ihrer herstellung.
US6555661B1 (en) * 1997-08-25 2003-04-29 Anthony R. Torres Simple, environmentally benign, method for purifying protein A
US5902722A (en) * 1997-12-05 1999-05-11 The Perkin-Elmer Corporation Method of detecting organisms in a sample
US6406909B1 (en) * 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
JP4363986B2 (ja) 2001-12-21 2009-11-11 イミュネックス・コーポレーション タンパク質の精製方法
US20040235139A1 (en) * 2002-12-23 2004-11-25 Demain Arnold L. Clostridium difficile culture and toxin production methods
EP1692269A4 (en) * 2003-12-12 2007-09-26 Sanofi Pasteur Ltd PRODUCTION OF DIPHTHERIA TOXIN
US20050282294A1 (en) * 2004-06-17 2005-12-22 Lothar Britsch Affinity supports with immobilised protein A
MY185597A (en) * 2005-09-20 2021-05-24 Avantor Performance Mat Inc Vegetarian protein a preparation and methods thereof

Also Published As

Publication number Publication date
JP2007039454A (ja) 2007-02-15
EP1748063A1 (en) 2007-01-31
US20070026489A1 (en) 2007-02-01
PL1748063T3 (pl) 2012-11-30
US20090060904A1 (en) 2009-03-05
EP1748063B1 (en) 2012-06-27
US7375188B2 (en) 2008-05-20

Similar Documents

Publication Publication Date Title
FI111336B (fi) Menetelmä Staphylococcus epidermidis tyyppi I:n polysakkaridiantigeenin sisältävän rokotteen ja antigeeninvastaisen hyperimmunoglobuliinin valmistamiseksi
AU585200B2 (en) Monoclonal antibodies reactive with endotoxin core
Kfir et al. Monoclonal antibody specific for cyanoginosin-LA: preparation and characterization
US20090060904A1 (en) Vegetarian Protein A Preparation and Methods Thereof
CN102458478B (zh) 白蛋白-淀粉样肽缀合物及其用途
WO2007035341A1 (en) Protein a production and purification without using animal derived components
ES2235228T3 (es) Procedimiento de purificacion de la toxina cm 101 del grupo gbs.
JPH01190635A (ja) 抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
CA2005119A1 (en) Use of basic amino acids to solubilize immunoglobulins
WO1989010133A1 (en) Stem cell inhibitors
ES2325584T3 (es) Purificacion de variantes de her-2.
EP1370289A2 (de) Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes
CN107216369A (zh) 一种鱼精蛋白类似活性肽及其制备方法与应用
CN117024564A (zh) 一种多肽改造体及其在制备抗炎杀菌药物中的应用
CN115819624B (zh) 一种重组融合蛋白及其制备方法和应用
CN105218660B (zh) 重组内皮抑素的新型纯化复性方法及其抗肿瘤应用
ES3062256A2 (es) METODOS DE PRODUCCION DE COMPOSICIONES QUE COMPRENDEN NEUROTOXINA DE CLOSTRIDIUM BOTULINUM SEROTIPO A (BoNT/A)
WO2003007874A2 (en) Anti-tumor activity from reptile serum
SU663714A1 (ru) Способ получени анатоксина
JPH03173899A (ja) 生体由来のタンパク質
CN114404614A (zh) 一种靶向铜绿假单胞菌的免疫脂质体及其制备方法和应用
JPH01247096A (ja) モノクローナル抗体の回収方法
PT92040A (pt) Processo para isolamento de interleucemia-2 glicosilada
TH160179A (th) การทำไอดิลโรเนต-2-ซัลฟาเตสให้บริสุทธิ์